Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats

The survival analysis results indicate that the esmolol infusion should be used in the early stages sepsis rats.Conclusion: Esmolol can suppress inflammation and apoptosis in the intestinal tissue via the overexpression of NF-kappa B-p65 in the early stage sepsis rats. kappa BEarly-stage use of esmolol might be an ideal treatment method for sepsis.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background/Aims: Accumulating evidence reveals esmolol could protect the gut mucosa through the regulation of immune response and inflammation inpatients with sepsis.

📊

Key Findings & Data:However, its underlying mechanism is not fully understood.Materials and Methods: Diamine oxidase (DAO), intestinal fatty acid-binding protein (I-FABP), interleukin (IL)-6, and IL-10 in the plasma of rats were detected by ELISA assay.

💡

Conclusion & Impact:The survival analysis results indicate that the esmolol infusion should be used in the early stages sepsis rats.Conclusion: Esmolol can suppress inflammation and apoptosis in the intestinal tissue via the overexpression of NF-kappa B-p65 in the early stage sepsis rats. kappa BEarly-stage use of esmolol might be an ideal treatment method for sepsis.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

Background/Aims: Accumulating evidence reveals esmolol could protect the gut mucosa through the regulation of immune response and inflammation inpatients with sepsis. However, its underlying mechanism is not fully understood.Materials and Methods: Diamine oxidase (DAO), intestinal fatty acid-binding protein (I-FABP), interleukin (IL)-6, and IL-10 in the plasma of rats were detected by ELISA assay. Western blotting was utilized to measure the expression levels of NF-kappa B-p65, Bcl-2, and cleaved caspase-3 in the intestinal tissues. The survival analysis was performed in each group.Results: The plasma levels of DAO and IL-10 levels were increased, whereas that of I-FABP and IL-6 were decreased in the sepsis rats after esmolol treatment, indicating that after the esmolol treatment, the intestinal inflammation and damages were remarkably reduced as compared to those in the normal saline treated sepsis rats. NF-κB-p65 and Bcl-2 were highly expressed, but cleaved caspase-3 showed lower expression in the esmolol treated groups. However, at the same time, we observed contrasting results in the normal saline treated group. Western blotting data indicated that the esmolol treatment inhibited the inflammation and apoptosis in the intestinal tissue due to the overexpression of NF-κB-p65 in the celiac sepsis rats. The survival analysis results indicate that the esmolol infusion should be used in the early stages sepsis rats.Conclusion: Esmolol can suppress inflammation and apoptosis in the intestinal tissue via the overexpression of NF-kappa B-p65 in the early stage sepsis rats. kappa BEarly-stage use of esmolol might be an ideal treatment method for sepsis.

🔖

Cite This Article

GUO, C., MA, L., SU, X., WANG, Y., ZHEN, L., ZHANG, B., AN, H., LİU, H. (2020). Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 4, 331–341. https://ajindex.com/articles/408683

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Rhee C, Dantes R, Epstein L, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. Jama 2017; 318: 1241-9. [Crossref] 2. Abraham E. New Definitions for Sepsis and Septic Shock: Continuing Evolution but With Much Still to Be Done. Jama 2016; 315: 757-9. [Crossref] 3. Singer M, Deutschman CS, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 2016; 315: 801-10. [Crossref] 4. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 2016; 315: 775-87. [Crossref] 5. Ikeh MAC, Fidel PL, Jr., Noverr MC. Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus. Infect Immun 2018; 86. pii: e00144-18. [Crossref] 6. Majka G, Wiecek G, Srottek M, et al. The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation. Biometals 2016; 29: 1019-33. [Crossref] 7. Calzavacca P, Lankadeva YR, Bailey SR, Bailey M, Bellomo R, May CN. Effects of selective beta1-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsis. Crit Care 2014; 18: 610. [Crossref] 8. Guo Y, Ren M, Ge L, et al. Increased Serum Concentrations of TNF-Like Weak Inducer of Apoptosis Predict Higher 28-Day Mortality in Patients with Sepsis. Emerg Med Int 2019; 2019: 7238705. [Crossref] 9. Jia Y, Li Z, Feng Y, et al. Methane-Rich Saline Ameliorates Sepsis-Induced Acute Kidney Injury through Anti-Inflammation, Antioxidative, and Antiapoptosis Effects by Regulating Endoplasmic Reticulum Stress. Oxid Med Cell Longev 2018; 2018: 4756846. [Crossref] 10. Dominguez JA, Vithayathil PJ, Khailova L, et al. Epidermal growth factor improves survival and prevents intestinal injury in a murine model of pseudomonas aeruginosa pneumonia. Shock 2011; 36: 381-9. [Crossref] 11. Sapin F, Biston P, Piagnerelli M. Predictive value of C-reactive protein in critically ill patients after abdominal surgery. Clinics (Sao Paulo) 2017; 72: 23-9. [Crossref] 12. Beesley SJ, Wilson EL, Lanspa MJ, et al. Relative Bradycardia in Patients with Septic Shock Requiring Vasopressor Therapy. Crit Care Med 2017; 45: 225-